Division of Neuroradiology, Department of Medical Imaging, University Health Network and the University of Toronto, Canada (E.A., M.D-A., D.M.M.).
Division of Neurology, University of Toronto, Canada (J.Z.).
Stroke. 2023 Jul;54(7):1808-1814. doi: 10.1161/STROKEAHA.122.042336. Epub 2023 Jun 7.
A venous pattern of infarction on neuroimaging is used as a clue to undiagnosed cerebral venous thrombosis (CVT); prevention of venous infarction is a goal of CVT management; and venous infarction is a factor used for clinical prognostication. Despite widespread use of the term venous infarct, the prevalence of true venous infarction is unclear. Our primary aim was to determine the prevalence of venous infarction in patients with CVT. We also measured the prevalence of diffusion abnormality without infarction, vasogenic edema, and intracranial hemorrhage.
Single-center, retrospective cohort study using a registry of 110 consecutive patients admitted to hospital with cerebral venous thrombosis between 2004 and 2014. Inclusion criteria were brain magnetic resonance imaging (MRI) and contrast-enhanced venography at presentation, and repeat brain MRI ≥1 month later. Exclusion criteria were dural arteriovenous fistula, arteriovenous malformation, cavernous sinus thrombosis, or previous neurosurgical procedure. Main outcome was proportion of patients with venous infarction (irreversible ischemic injury) diagnosed using diffusion-weighted MRI at presentation, confirmed using T2-weighted fluid-attenuated inversion recovery MRI ≥1 month later, and reported with 95% CI using the Wilson score interval method. We also report the prevalence of transient diffusion MRI abnormality without infarction, vasogenic edema, and intracranial hemorrhage.
Seventy-three patients met the inclusion criteria, and after exclusions, the final study population was 59 patients with median age 41 years (interquartile range, 32-57). Venous infarction occurred in 12% (7/59 [95% CI, 6%-23%]) of patients, and final infarct volume was >1 mL in only 5.1% (3/59) of patients. An additional 8% (5/59 [95% CI, 4%-18%]) of patients had a transient diffusion MRI abnormality without infarction. Prevalence of cerebral vasogenic edema and intracranial hemorrhage were 66% (39/59 [95% CI, 53%-77%]) and 54% (32/59 [95% CI, 41%-66%]), respectively.
In patients with CVT, venous infarction is uncommon and venous infarcts are typically very small. Vasogenic edema and hemorrhage are more common consequences of CVT.
神经影像学上的静脉梗死模式可作为未确诊的脑静脉血栓形成(CVT)的线索;预防静脉梗死是 CVT 管理的目标;静脉梗死是用于临床预后评估的因素。尽管广泛使用“静脉梗死”一词,但真正的静脉梗死的患病率尚不清楚。我们的主要目的是确定 CVT 患者中静脉梗死的患病率。我们还测量了无梗死的弥散异常、血管源性水肿和颅内出血的患病率。
这是一项单中心、回顾性队列研究,纳入了 2004 年至 2014 年间因脑静脉血栓形成住院的 110 例连续患者的登记资料。纳入标准为入院时进行脑磁共振成像(MRI)和对比增强静脉造影,且 1 个月后重复进行脑 MRI。排除标准为硬脑膜动静脉瘘、动静脉畸形、海绵窦血栓形成或既往神经外科手术。主要结局为使用弥散加权 MRI 于入院时诊断静脉梗死(不可逆性缺血损伤)的患者比例,使用 T2 加权液体衰减反转恢复 MRI 于 1 个月后确诊,并使用 Wilson 评分区间法报告 95%置信区间。我们还报告了无梗死的短暂弥散 MRI 异常、血管源性水肿和颅内出血的患病率。
73 例患者符合纳入标准,排除后,最终研究人群为 59 例患者,中位年龄为 41 岁(四分位距,32-57 岁)。12%(7/59[95%CI,6%-23%])的患者发生静脉梗死,仅有 5.1%(3/59)的患者最终梗死体积>1mL。另外 8%(5/59[95%CI,4%-18%])的患者出现无梗死的短暂弥散 MRI 异常。脑血管源性水肿和颅内出血的患病率分别为 66%(39/59[95%CI,53%-77%])和 54%(32/59[95%CI,41%-66%])。
在 CVT 患者中,静脉梗死并不常见,且静脉梗死通常非常小。血管源性水肿和出血是 CVT 更常见的后果。